DNA ‘reverse’ vaccine reduces levels of immune cells believed responsible for type-1 diabetes, study shows.

by mratner

 

BY BRUCE GOLDMAN

 Lawrence Steinman
 

A clinical trial of a vaccine, led by Stanford University School of Medicine researchers and designed to combat type-1 diabetes, has delivered initially promising results, suggesting that it may selectively counter the errant immune response that causes the disease.

Read the rest of the article here

 

Advertisements